Key result
Elevated miR-26b is linked to ~47% lower LVH risk and better diastolic function in elderly hypertensives.
Why the study?
To evaluate the correlations of circulating miR-26b level with left ventricular hypertrophy and cardiac function in elderly patients with hypertension.
Is circulating miR-26b level correlated with left ventricular hypertrophy and cardiac function in elderly patients with hypertension?
Cross-Sectional (n=132)
No
Is circulating miR-26b level correlated with left ventricular hypertrophy and cardiac function in elderly patients with hypertension?
Odds Ratio: 0.528 (95% CI 0.257–0.895)
Absolute Event Rate: 23.21% vs 92.11%
p-value: p=<0.001
Circulating miR-26b is a potential biomarker for diagnosing left ventricular hypertrophy and diastolic dysfunction in elderly hypertensive patients.
Hypothesis-generating for miR-26b as biomarker in elderly hypertensive LVH; prospective validation required before clinical use.
Objectives: To study the correlations of circulating miR-26b level with left ventricular hypertrophy (LVH) and cardiac function in elderly patients with hypertension. Methods: A total of 132 eligible patients were divided into low and high miR-26b level groups. Their baseline clinical data and biochemical indices were compared. The correlations between miR-26b level and echocardiographic parameters were studied by Pearson’s analysis. Factors affecting LVH were explored by multivariate logistic regression analysis. The role of miR-26b in diagnosing LVH was predicted by receiver operating characteristic curve. Results: The relative expression level of miR-26b was 4.56-16.93, with a median of 7.62. The two groups had similar baseline clinical data and biochemical indices (P>0.05). Compared with high miR-26b level group, interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPWT), left ventricular mass index (LVMI) and number of LVH cases in low miR-26b level group significantly increased (P<0.05), and mitral ratio of peak early to late diastolic filling velocity (E/A) decreased (P<0.05). Circulating miR-26b level was negatively correlated with IVST, LVPWT and LVMI (P<0.0001), and positively correlated with E/A (P<0.0001). The proportion of cardiac hypofunction cases in low miR-26b level group significantly exceeded that of high miR-26b level group (P<0.05). Age and increased IVST, LVPWT and LVMI were independent risk factors for LVH (P<0.05), and elevated miR-26b level was a protective factor (P<0.05). AUC was 0.836, and the optimal cutoff value was 8.83, with high sensitivity and specificity. Conclusions: MiR-26b level is negatively correlated with LVH and positively correlated with left ventricular diastolic function in elderly hypertensive patients. It is a protective factor for LVH complicated with diastolic dysfunction and a potential biomarker for diagnosis. doi: https://doi.org/10.12669/pjms.37.4.4048 How to cite this:Fu J, Lin F, Pan Z, Wu C. Correlations of circulating miR-26b level with left ventricular hypertrophy and cardiac function in elderly patients with hypertension. Pak J Med Sci. 2021;37(4):966-971. doi: https://doi.org/10.12669/pjms.37.4.4048 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2021) conducted a cross-sectional in Hypertension (n=132). Elevated circulating miR-26b level (≥7.62) vs. Low circulating miR-26b level (<7.62) was evaluated on Left ventricular hypertrophy (LVH) (OR 0.528, 95% CI 0.257-0.895, p=<0.001). Elevated circulating miR-26b levels were associated with a significantly lower risk of left ventricular hypertrophy (OR 0.528) and better diastolic function in elderly patients with hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: